Concepts (169)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Dengue Virus | 6 | 2018 | 910 | 1.51 | Why? |
| Dengue | 6 | 2018 | 1565 | 1.06 | Why? |
| Dengue Vaccines | 2 | 2018 | 123 | 0.81 | Why? |
| Zika Virus Infection | 3 | 2017 | 1920 | 0.77 | Why? |
| Flavivirus Infections | 1 | 2018 | 81 | 0.72 | Why? |
| Germ-Line Mutation | 1 | 2017 | 86 | 0.69 | Why? |
| Antibodies, Monoclonal | 8 | 2021 | 8041 | 0.68 | Why? |
| Flavivirus | 1 | 2018 | 182 | 0.64 | Why? |
| Zika Virus | 3 | 2017 | 1924 | 0.62 | Why? |
| Receptors, Antigen, T-Cell, alpha-beta | 1 | 2017 | 203 | 0.62 | Why? |
| Microcephaly | 1 | 2017 | 181 | 0.60 | Why? |
| West Nile Fever | 1 | 2017 | 166 | 0.57 | Why? |
| Antibodies, Neutralizing | 10 | 2021 | 25288 | 0.56 | Why? |
| Antibodies, Viral | 18 | 2021 | 51949 | 0.53 | Why? |
| Immunodominant Epitopes | 2 | 2020 | 813 | 0.51 | Why? |
| Cross Reactions | 4 | 2021 | 4374 | 0.50 | Why? |
| Adaptive Immunity | 2 | 2018 | 2585 | 0.39 | Why? |
| CHO Cells | 3 | 2021 | 831 | 0.38 | Why? |
| Cricetulus | 3 | 2021 | 936 | 0.37 | Why? |
| Viral Envelope Proteins | 2 | 2018 | 3539 | 0.36 | Why? |
| Vero Cells | 8 | 2021 | 14117 | 0.35 | Why? |
| Spike Glycoprotein, Coronavirus | 8 | 2021 | 37182 | 0.34 | Why? |
| HEK293 Cells | 5 | 2021 | 8394 | 0.33 | Why? |
| CD8-Positive T-Lymphocytes | 4 | 2021 | 5837 | 0.31 | Why? |
| Immunity | 1 | 2017 | 2651 | 0.30 | Why? |
| Crystallography, X-Ray | 4 | 2021 | 2689 | 0.29 | Why? |
| Protein Structure, Tertiary | 2 | 2021 | 1565 | 0.28 | Why? |
| Aedes | 2 | 2017 | 380 | 0.26 | Why? |
| Drug Discovery | 1 | 2017 | 3092 | 0.24 | Why? |
| Models, Molecular | 4 | 2021 | 7616 | 0.24 | Why? |
| Antigen-Antibody Complex | 2 | 2021 | 408 | 0.24 | Why? |
| Hemagglutination Tests | 1 | 2021 | 124 | 0.21 | Why? |
| Neutralization Tests | 4 | 2021 | 6698 | 0.21 | Why? |
| Protein Binding | 3 | 2021 | 11430 | 0.20 | Why? |
| Binding Sites, Antibody | 1 | 2021 | 466 | 0.20 | Why? |
| Animals | 10 | 2021 | 78931 | 0.19 | Why? |
| Pregnancy Trimester, First | 1 | 2020 | 366 | 0.18 | Why? |
| Viral Vaccines | 4 | 2020 | 7560 | 0.18 | Why? |
| Protein Domains | 3 | 2021 | 6563 | 0.17 | Why? |
| Serotyping | 1 | 2017 | 154 | 0.17 | Why? |
| Drosophila | 1 | 2017 | 55 | 0.17 | Why? |
| Complementarity Determining Regions | 1 | 2017 | 147 | 0.16 | Why? |
| Disulfides | 1 | 2017 | 161 | 0.16 | Why? |
| Immunization, Passive | 3 | 2021 | 10067 | 0.16 | Why? |
| Immunologic Memory | 3 | 2021 | 3362 | 0.15 | Why? |
| HLA-A Antigens | 1 | 2017 | 196 | 0.15 | Why? |
| West Nile virus | 1 | 2017 | 206 | 0.15 | Why? |
| Disease Vectors | 1 | 2017 | 208 | 0.15 | Why? |
| Surface Plasmon Resonance | 1 | 2017 | 440 | 0.15 | Why? |
| Enzyme-Linked Immunosorbent Assay | 6 | 2021 | 7868 | 0.15 | Why? |
| Liposomes | 1 | 2017 | 334 | 0.14 | Why? |
| Immunoglobulin G | 5 | 2021 | 21571 | 0.14 | Why? |
| Structure-Activity Relationship | 1 | 2021 | 2219 | 0.13 | Why? |
| Mutation | 3 | 2021 | 12376 | 0.13 | Why? |
| Mice, Transgenic | 1 | 2021 | 2739 | 0.13 | Why? |
| Vaccination | 2 | 2021 | 19050 | 0.13 | Why? |
| Population Surveillance | 2 | 2020 | 4967 | 0.13 | Why? |
| Epitope Mapping | 1 | 2017 | 1240 | 0.12 | Why? |
| Epitopes | 2 | 2021 | 4113 | 0.11 | Why? |
| Protein Multimerization | 1 | 2017 | 1336 | 0.11 | Why? |
| Nitric Oxide | 1 | 2017 | 769 | 0.10 | Why? |
| Blood Donors | 2 | 2020 | 2956 | 0.10 | Why? |
| Epitopes, T-Lymphocyte | 2 | 2020 | 2262 | 0.10 | Why? |
| Humans | 29 | 2021 | 930598 | 0.10 | Why? |
| Amino Acid Sequence | 2 | 2020 | 6049 | 0.10 | Why? |
| Mice | 2 | 2021 | 21357 | 0.10 | Why? |
| CD4-Positive T-Lymphocytes | 2 | 2021 | 4545 | 0.09 | Why? |
| Immunoassay | 2 | 2021 | 4485 | 0.09 | Why? |
| Endothelium, Vascular | 1 | 2017 | 1751 | 0.08 | Why? |
| Viral Structural Proteins | 1 | 2009 | 491 | 0.08 | Why? |
| Health Personnel | 5 | 2021 | 29646 | 0.07 | Why? |
| Th2 Cells | 1 | 2008 | 680 | 0.07 | Why? |
| Cell Membrane | 1 | 2009 | 743 | 0.07 | Why? |
| T-Lymphocytes | 1 | 2021 | 6670 | 0.06 | Why? |
| Antigens, Viral | 1 | 2020 | 6298 | 0.06 | Why? |
| Lectins, C-Type | 1 | 2005 | 405 | 0.06 | Why? |
| Cell Adhesion Molecules | 1 | 2005 | 472 | 0.06 | Why? |
| Cryoelectron Microscopy | 2 | 2020 | 2372 | 0.06 | Why? |
| Receptors, Cell Surface | 1 | 2005 | 586 | 0.06 | Why? |
| Serine Endopeptidases | 1 | 2017 | 4606 | 0.06 | Why? |
| Clinical Trials as Topic | 1 | 2021 | 7330 | 0.06 | Why? |
| Agglutination Tests | 1 | 2021 | 124 | 0.05 | Why? |
| Seroepidemiologic Studies | 3 | 2021 | 10017 | 0.05 | Why? |
| Seroconversion | 2 | 2021 | 2515 | 0.05 | Why? |
| SARS Virus | 3 | 2009 | 13021 | 0.05 | Why? |
| United Kingdom | 4 | 2021 | 18046 | 0.05 | Why? |
| Betacoronavirus | 6 | 2020 | 204454 | 0.05 | Why? |
| Sensitivity and Specificity | 4 | 2021 | 22971 | 0.05 | Why? |
| Allosteric Site | 1 | 2020 | 211 | 0.05 | Why? |
| Arginase | 1 | 2017 | 64 | 0.04 | Why? |
| Geography, Medical | 1 | 2020 | 537 | 0.04 | Why? |
| Prenatal Diagnosis | 1 | 2020 | 345 | 0.04 | Why? |
| Inhibitory Concentration 50 | 1 | 2020 | 907 | 0.04 | Why? |
| Immunoglobulin Fab Fragments | 1 | 2020 | 556 | 0.04 | Why? |
| Single-Blind Method | 1 | 2020 | 1283 | 0.04 | Why? |
| Scotland | 1 | 2020 | 1119 | 0.04 | Why? |
| Adult | 11 | 2021 | 244371 | 0.04 | Why? |
| CD4 Lymphocyte Count | 1 | 2021 | 1517 | 0.04 | Why? |
| Male | 10 | 2021 | 367725 | 0.04 | Why? |
| Polymerase Chain Reaction | 2 | 2021 | 6740 | 0.04 | Why? |
| Pneumonia, Viral | 6 | 2020 | 243684 | 0.04 | Why? |
| Coronavirus Infections | 6 | 2020 | 253789 | 0.04 | Why? |
| HIV Infections | 1 | 2021 | 11620 | 0.04 | Why? |
| Models, Immunological | 1 | 2020 | 727 | 0.04 | Why? |
| Arginine | 1 | 2017 | 377 | 0.04 | Why? |
| Pregnancy Complications, Infectious | 1 | 2020 | 11559 | 0.03 | Why? |
| Pandemics | 8 | 2021 | 389249 | 0.03 | Why? |
| Cell Proliferation | 1 | 2021 | 1973 | 0.03 | Why? |
| Severe Acute Respiratory Syndrome | 2 | 2008 | 12361 | 0.03 | Why? |
| Female | 8 | 2021 | 380317 | 0.03 | Why? |
| Ageusia | 1 | 2021 | 918 | 0.03 | Why? |
| Hospitals, Teaching | 1 | 2020 | 1609 | 0.03 | Why? |
| Cluster Analysis | 1 | 2020 | 3001 | 0.03 | Why? |
| Bayes Theorem | 1 | 2021 | 3237 | 0.03 | Why? |
| Asymptomatic Infections | 2 | 2021 | 7218 | 0.03 | Why? |
| Interferon-gamma | 1 | 2021 | 2711 | 0.03 | Why? |
| ADP-Ribosylation Factor 1 | 1 | 2009 | 19 | 0.03 | Why? |
| Recurrence | 1 | 2020 | 3675 | 0.03 | Why? |
| Virion | 1 | 2018 | 1444 | 0.03 | Why? |
| Urban Population | 1 | 2020 | 2000 | 0.03 | Why? |
| Cytoplasmic Vesicles | 1 | 2009 | 74 | 0.02 | Why? |
| Lysosomal-Associated Membrane Protein 1 | 1 | 2008 | 27 | 0.02 | Why? |
| Protein Conformation | 1 | 2020 | 4386 | 0.02 | Why? |
| Golgi Apparatus | 1 | 2009 | 178 | 0.02 | Why? |
| Disease Outbreaks | 1 | 2017 | 27595 | 0.02 | Why? |
| Adolescent | 4 | 2020 | 86841 | 0.02 | Why? |
| Host-Pathogen Interactions | 1 | 2009 | 11041 | 0.02 | Why? |
| Tumor Necrosis Factor Receptor Superfamily, Member 7 | 1 | 2008 | 58 | 0.02 | Why? |
| Peptidyl-Dipeptidase A | 2 | 2020 | 9659 | 0.02 | Why? |
| Leukocyte Common Antigens | 1 | 2008 | 101 | 0.02 | Why? |
| Peptides | 1 | 2021 | 2513 | 0.02 | Why? |
| Young Adult | 4 | 2020 | 93724 | 0.02 | Why? |
| England | 1 | 2020 | 5116 | 0.02 | Why? |
| Incidence | 2 | 2020 | 25622 | 0.02 | Why? |
| ROC Curve | 1 | 2020 | 6024 | 0.02 | Why? |
| Prevalence | 2 | 2020 | 25773 | 0.02 | Why? |
| Risk | 1 | 2020 | 5288 | 0.02 | Why? |
| Antiviral Agents | 1 | 2021 | 41703 | 0.02 | Why? |
| Gene Deletion | 1 | 2009 | 430 | 0.02 | Why? |
| Antibody Formation | 1 | 2021 | 4038 | 0.02 | Why? |
| Binding Sites | 1 | 2020 | 6201 | 0.02 | Why? |
| Point-of-Care Systems | 1 | 2021 | 2955 | 0.02 | Why? |
| Cell Death | 1 | 2009 | 536 | 0.02 | Why? |
| Middle Aged | 6 | 2021 | 270681 | 0.02 | Why? |
| Transfection | 1 | 2009 | 864 | 0.02 | Why? |
| Tandem Repeat Sequences | 1 | 2005 | 78 | 0.02 | Why? |
| Longitudinal Studies | 1 | 2020 | 9893 | 0.02 | Why? |
| Cohort Studies | 3 | 2020 | 36005 | 0.02 | Why? |
| Homozygote | 1 | 2005 | 230 | 0.02 | Why? |
| Proteasome Endopeptidase Complex | 1 | 2005 | 249 | 0.02 | Why? |
| Cytokines | 2 | 2021 | 15010 | 0.02 | Why? |
| Receptors, Virus | 1 | 2020 | 5659 | 0.02 | Why? |
| Intestine, Small | 1 | 2005 | 336 | 0.02 | Why? |
| Virus Internalization | 1 | 2020 | 7921 | 0.01 | Why? |
| Molecular Sequence Data | 1 | 2005 | 3198 | 0.01 | Why? |
| Age Factors | 1 | 2020 | 21039 | 0.01 | Why? |
| Proteome | 1 | 2008 | 1812 | 0.01 | Why? |
| Pregnancy | 1 | 2020 | 23879 | 0.01 | Why? |
| Cricetinae | 1 | 2005 | 3344 | 0.01 | Why? |
| Infectious Disease Transmission, Patient-to-Professional | 1 | 2020 | 9706 | 0.01 | Why? |
| Hong Kong | 1 | 2005 | 3361 | 0.01 | Why? |
| Biomarkers | 1 | 2017 | 23361 | 0.01 | Why? |
| Aged | 2 | 2020 | 215776 | 0.01 | Why? |
| Intensive Care Units | 1 | 2020 | 29594 | 0.01 | Why? |
| Surveys and Questionnaires | 1 | 2020 | 43792 | 0.01 | Why? |
| Prospective Studies | 1 | 2017 | 43301 | 0.01 | Why? |
| Genetic Predisposition to Disease | 1 | 2005 | 4027 | 0.01 | Why? |
| Aged, 80 and over | 1 | 2020 | 88759 | 0.01 | Why? |
| Lung | 1 | 2005 | 31049 | 0.00 | Why? |
Screaton's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(169)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(464)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_